Sitemap

Zoran Marinković, CEO, ZWEBB Fintech

Fintech Brings Prosperity

Much has changed in terms of Fintech’s positioning in Serbia and the region, but still not enough, says ZWEBB Fintech CEO Zoran Marinković We spoke...

Ivan Đolić, BE-terna Managing Director

BE-terna Provides the Tools for Success

In an era in which digital transformation, AI and analytics are shaping the future of business, BE-terna remains committed to developing solutions that deliver...

Rajka Šinik Vulić, Director of RBS Belgrade

Shaping the Future of Business Education

RBS Belgrade has established itself as a key player in the development of business education around the region, offering high-quality programmes that are recognised...

Erich Cossutta, President of the Danubia Group

Leading Sustainability and Digitalisation in Transport

Companies Dragon Maritime, Log Max and Kombi Pro have now been operating for a full year under the umbrella of the Danubia Group, which...

Milen Janjić, CEO, Intellya

IT Maturity on the Rise

Our eight years of work has resulted in a suite of platforms: AI CORE, the foundation of our development; Weaver, a conversational platform; and...

Danilo Mijušković, President of the FIC Pharma Industry Committee (Merck)

Partners for Technological Change

The pharmaceutical industry in Serbia can offer the state its experience and expertise in order to drive technological advancement in areas such as healthcare digitalisation and the application of artificial intelligence

At the FIC Pharmaceutical Industry Committee, we believe that one of the key advances in Serbia’s pharmaceutical industry is the state’s increasing investment in improving the availability of new therapeutic options. In practice, this means greater access to medicines and improved healthcare for patients in Serbia. However, these funds still aren’t sufficient to fully meet the needs of patients, and we are not yet at the level of medicine availability seen in the European Union, though we are certainly on track to achieving that.

Globally, we live in an exceptionally challenging environment when it comes to medicine supply. We are witnessing global shortages of some extremely important medicines. Economic crises, wars, labour shortages and rising production costs are just a few of the reasons for potential supply disruptions. Given all these factors, the role of the pharmaceutical industry in Serbia is becoming increasingly significant. I am confident that the industry, in cooperation with the state, will work to ensure the most stable medicine supply possible.

To maintain and improve the availability of innovative and generic medicines in Serbia, we need to focus on a few key steps: long-term savings through the use of efficient and modern therapies with preventative measures; analysis of the effectiveness of therapy; accelerating procedures for registering and introducing as many innovative and generic medicines as possible to the Drug Lists in Serbia. An active dialogue between institutions, companies and experts is an essential condition for any discussion about the progress of healthcare today.

Easier Access to Healthcare for All

We aim to improve dialogue and foster better, more efficient cooperation with state institutions, ensuring that every citizen has faster and easier access to healthcare

We’ve made progress in Serbia in terms of building partnerships and improving dialogue with the Ministry of Health, the National Health Insurance Fund and the Medicines and Medical Devices Agency, to ensure the provision of the most efficient and effective healthcare to all citizens.

I would also like to highlight the fact that the pharmaceutical industry in Serbia can offer the state its experience and expertise in order to drive technological advancements in areas such as healthcare digitalisation and the application of artificial intelligence. Digitalisation and the use of artificial intelligence bring many benefits to healthcare, from improving diagnostics and personalising medicine to suit patients’ individual needs, to speeding up administrative processes that become more efficient, freeing up healthcare workers to focus on direct patient care. The fast processing and sharing of medical data enhances analytics and the evaluation of the effectiveness of different therapeutic options. All these changes together make the healthcare system more efficient, precise and accessible, where the pharmaceutical industry can assist in various partnership projects with state institutions.

This is why the FIC Pharmaceutical Industry Committee will be very active, as we see this moment as representing the right time to launch new ideas and new solutions.

We want to work to improve dialogue and establish more effective cooperation with state institutions, so that every citizen can have faster and easier access to healthcare.

Loucas Fourlas, MEP Chair of the EU Delegation to the Serbia-EU Stabilisation and Association Parliamentary Committee

Serbia Needs Europe, and Europe Needs Serbia

Unity and democracy are the only answers to any problems and challenges. Calmness, dialogue and respect for democracy — this is what Serbia needs,...

H.E. Maria Levanti, Greek Ambassador to Serbia

Support From an Old Friend

The recent letter of Greek Prime Minister Kyriakos Mitsotakis in support of Serbia’s EU path, addressed to his EU counterparts and heads of EU...

Aleksandar Vlahović. President of the Serbian Association of Economists

The Winning Approach is Modern and Transparent

Serbia must modernise, change its economic structure and increase its productivity and competitiveness. Existing policies don’t pay sufficient attention to these objectives This year’s Kopaonik...

Nikolaos Sliousaregko, President of the Management Board of the Hellenic Business Association of Serbia (HBA)

Working Well, With Room to Improve

In many sectors that are a priority for Serbia – from agriculture and various segments of the processing, industry to services related to transport,...

Carlsberg Rejoins UEFA’s Global Stage

Carlsberg's return to the European football scene marks a new chapter in its decades-long commitment to the sport, as...

EU Summit Discusses Western Balkans Integration

The European Council summit held in Brussels on March 20, 2025, placed a strong emphasis on the integration of...

Business Forum Strengthens Economic Ties Between Serbia and China

On March 20th, the Serbian Chamber of Commerce hosted a significant Business Forum and a series of bilateral meetings...

Norwegian Fund Acquires 25% of Covent Garden

In a strategic show of confidence in London's commercial heart, Norway’s sovereign wealth fund secures a quarter stake in...

ECB Cuts Interest Rates Amid Trade Uncertainty

In a move aimed at supporting Europe’s economy, the European Central Bank (ECB) has announced a series of interest...

Carlsberg Rejoins UEFA’s Global Stage

Carlsberg's return to the European football scene marks a new chapter in its decades-long commitment to the sport, as...

EU Summit Discusses Western Balkans Integration

The European Council summit held in Brussels on March 20, 2025, placed a strong emphasis on the integration of...

ECB Cuts Interest Rates Amid Trade Uncertainty

In a move aimed at supporting Europe’s economy, the European Central Bank (ECB) has announced a series of interest...

EU’s ETIAS Travel System Delayed Again

The EU's long-awaited ETIAS system, set to impose new travel rules for Schengen zone entry, faces yet another delay....

France Dominates Europe’s Startup Ecosystem in 2024

France's strategic policies and inclusive ecosystem continue to set the gold standard for European startups, securing its top spot...

Carlsberg Rejoins UEFA’s Global Stage

Carlsberg's return to the European football scene marks a new chapter in its decades-long commitment to the sport, as...

EU Summit Discusses Western Balkans Integration

The European Council summit held in Brussels on March 20, 2025, placed a strong emphasis on the integration of...

ECB Cuts Interest Rates Amid Trade Uncertainty

In a move aimed at supporting Europe’s economy, the European Central Bank (ECB) has announced a series of interest...

EU’s ETIAS Travel System Delayed Again

The EU's long-awaited ETIAS system, set to impose new travel rules for Schengen zone entry, faces yet another delay....

France Dominates Europe’s Startup Ecosystem in 2024

France's strategic policies and inclusive ecosystem continue to set the gold standard for European startups, securing its top spot...
spot_img